Literature DB >> 12810255

Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization.

Jun Nishio1, Hiroshi Iwasaki, Masako Ishiguro, Yuko Ohjimi, Noriko Nishimura, Takamasa Koga, Tatsuhiko Kawarabayashi, Yasuhiko Kaneko, Masahiro Kikuchi.   

Abstract

Although a number of malignant fibrous histiocytoma (MFH) cell lines have been reported, their characterization at a molecular cytogenetic level has not been fully established. In this study, we established a new human cell line, designated as FU-MFH-1, from a storiform-pleomorphic MFH arising in the retroperitoneum of a 61-year-old woman, and applied comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) with chromosome painting probes for the characterization of chromosome alterations. FU-MFH-1 cells were spindle, round, or polygonal in shape with oval nuclei, and were maintained continuously in vitro for over 50 passages for more than 12 months. G-banding analysis was performed and FU-MFH-1 revealed a complex karyotype with an abnormal chromosome 19 containing a homogeneously staining region (hsr). CGH analysis showed a high-level amplification of 12q13-->q21. The high-level amplification detected by CGH was refined by FISH. These results showed that the hsr was composed of amplified DNA sequences from 12q. Our study emphasizes the usefulness of CGH as a powerful tool for chromosomal localization of amplified sequences. The FU-MFH-1 cell line should be useful for biologic and molecular pathogenetic investigations of human MFH.

Entities:  

Mesh:

Year:  2003        PMID: 12810255     DOI: 10.1016/s0165-4608(02)00925-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation.

Authors:  T Ohguri; M Hisaoka; S Kawauchi; K Sasaki; T Aoki; S Kanemitsu; A Matsuyama; Y Korogi; H Hashimoto
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

2.  Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masako Ishiguro; Teruto Isayama; Masatoshi Naito
Journal:  J Exp Clin Cancer Res       Date:  2010-11-24

3.  Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung.

Authors:  Tsunenari Maeda; Susumu Hashitani; Yusuke Zushi; Emi Segawa; Noriaki Tanaka; Kazunari Sakurai; Masahiro Urade
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-04       Impact factor: 4.553

4.  Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.

Authors:  Rosario Gil-Benso; Javier Megías; Teresa San-Miguel; Sandra Pinto; Robert C Callaghan; Concha López-Ginés; Miguel Cerdá-Nicolás
Journal:  Cytotechnology       Date:  2017-07-04       Impact factor: 2.058

5.  Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.

Authors:  Alessandro De Vita; Federica Recine; Laura Mercatali; Giacomo Miserocchi; Chiara Spadazzi; Chiara Liverani; Alberto Bongiovanni; Federica Pieri; Roberto Casadei; Nada Riva; Valentina Fausti; Dino Amadori; Toni Ibrahim
Journal:  Int J Mol Sci       Date:  2017-12-08       Impact factor: 5.923

6.  Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues.

Authors:  Chao Shen; Meijia Gu; Dan Liang; Lixia Miao; Liu Hu; Congyi Zheng; Jiakuan Chen
Journal:  Cancer Cell Int       Date:  2009-01-02       Impact factor: 5.722

7.  Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening.

Authors:  Iwona Grad; Robert Hanes; Pilar Ayuda-Durán; Marieke Lydia Kuijjer; Jorrit M Enserink; Leonardo A Meza-Zepeda; Ola Myklebost
Journal:  PLoS One       Date:  2021-03-10       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.